AAA today announced its financial results for fiscal 2016. On Track to Resubmit NDA for lutetium Lu 177 dotatate (Lutathera®) to FDA in Mid-2017.
AAA today announced its financial results for fiscal 2016. On Track to Resubmit NDA for lutetium Lu 177 dotatate (Lutathera®) to FDA in Mid-2017.